title: Cabazitaxel for metastatic hormone-relapsed prostate cancer treated with docetaxel.
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK. Electronic address: Rosie.Lovett@nice.org.uk.
authors.forename: Rosemary
authors.initials: R
authors.lastname: Lovett
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Victoria
authors.initials: V
authors.lastname: Kelly
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Melinda
authors.initials: M
authors.lastname: Goodall
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Amanda I
authors.initials: AI
authors.lastname: Adler
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077143:Docetaxel; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; C552428:cabazitaxel